Quantitative global proteome and phosphorylome analyses reveal potential biomarkers in kidney cancer.

Xu, Liwei; Lu, Zeyi; Yu, Shicheng; Li, Gonghui; Chen, Yuanlei

Xu, Liwei; Lu, Zeyi; Yu, Shicheng; Li, Gonghui; Chen, Yuanlei.

Affiliation

Xu L; Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, P.R. China.
Lu Z; Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, P.R. China.
Yu S; Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, P.R. China.
Li G; Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, P.R. China.
Chen Y; Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, P.R. China.

Oncol Rep ; 46(5)2021 11.

Article de En | MEDLINE | ID: mdl-34528699

Sujet(s)
Mots clés

biomarkers; pathways; phosphorylome; proteome; renal cell carcinoma

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Néphrocarcinome / Marqueurs biologiques tumoraux / Protéome / Tumeurs du rein Type d'étude: Prognostic_studies Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: Oncol Rep Sujet du journal: NEOPLASIAS Année: 2021 Type de document: Article Pays de publication: Grèce

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google